GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Inventories, Finished Goods

CellSource Co (TSE:4880) Inventories, Finished Goods : 円98 Mil (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Inventories, Finished Goods?

CellSource Co's quarterly finished goods increased from Jul. 2023 (円135 Mil) to Oct. 2023 (円153 Mil) but then declined from Oct. 2023 (円153 Mil) to Jan. 2024 (円98 Mil).

CellSource Co's annual finished goods increased from Oct. 2021 (円92 Mil) to Oct. 2022 (円121 Mil) and increased from Oct. 2022 (円121 Mil) to Oct. 2023 (円153 Mil).


CellSource Co Inventories, Finished Goods Historical Data

The historical data trend for CellSource Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Inventories, Finished Goods Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Inventories, Finished Goods
Get a 7-Day Free Trial 99.26 84.55 91.56 121.35 153.45

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.48 123.12 134.81 153.45 98.34

CellSource Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines